John Russel Denton serves as Executive at Caris Life Sciences, Inc., where they oversee executive responsibilities. Since joining the company, John Russel Denton has executed 1 insider transactions totaling $100.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 7, 2025 involved purchasing 4,184 shares valued at $100.8K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 7, 2025 | CAI | $100.8K | Purchase | 4,184 | $24.09 | Discretionary |
John Russel Denton currently holds 9,184 shares of Caris Life Sciences, Inc. (CAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Russel Denton has been a net buyer of CAI stock. They have purchased $100.8K and sold $0 worth of shares.
John Russel Denton's most recent insider trade was on Nov 7, 2025, when they purchased 4,184 shares at $24.09 per share.
Get notified when new Form 4 filings are submitted